# A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

> **NCT06810583** · PHASE1 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 29 (estimated)

## Conditions studied

- Leukemia
- Acute Myeloid Leukemia
- Lymphoblastic Leukemia in Children

## Interventions

- **DRUG:** Dalbavancin
- **DRUG:** Fluoroquinolone (either ciprofloxacin or levofloxacin at the discretion of the treating clinician)

## Key facts

- **NCT ID:** NCT06810583
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-22
- **Primary completion:** 2030-09
- **Final completion:** 2031-09
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810583, "A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06810583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*